Related references
Note: Only part of the references are listed.Glutamine-free mammalian expression of recombinant glycoproteins with uniform isotope labeling: an application for NMR analysis of pharmaceutically relevant Fc glycoforms of human immunoglobulin G1
Saeko Yanaka et al.
JOURNAL OF BIOMOLECULAR NMR (2022)
HDX-MS and MD Simulations Provide Evidence for Stabilization of the IgG1-FcγRIa (CD64a) Immune Complex Through Intermolecular Glycoprotein Bonds
Kyle W. Anderson et al.
JOURNAL OF MOLECULAR BIOLOGY (2022)
The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa
Yuki Yamaguchi et al.
MABS (2022)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
Kevin O. Saunders
FRONTIERS IN IMMUNOLOGY (2019)
The Fab portion of immunoglobulin G contributes to its binding to Fcγ receptor III
Rina Yogo et al.
SCIENTIFIC REPORTS (2019)
Dynamic Views of the Fc Region of Immunoglobulin G Provided by Experimental and Computational Observations
Saeko Yanaka et al.
ANTIBODIES (2019)
Characterization of therapeutic antibodies in the presence of human serum proteins by AU-FDS analytical ultracentrifugation
Robert T. Wright et al.
ANALYTICAL BIOCHEMISTRY (2018)
Backbone 1H, 13C, and 15N assignments of the extracellular region of human Fcγ receptor IIIb
Rina Yogo et al.
BIOMOLECULAR NMR ASSIGNMENTS (2018)
Stable isotope labeling approaches for NMR characterization of glycoproteins using eukaryotic expression systems
Saeko Yanaka et al.
JOURNAL OF BIOMOLECULAR NMR (2018)
Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
Masato Kiyoshi et al.
SCIENTIFIC REPORTS (2018)
Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments
Elena Krayukhina et al.
MABS (2017)
NMR Detection of Semi-Specific Antibody Interactions in Serum Environments
Saeko Yanaka et al.
MOLECULES (2017)
Therapeutic Antibodies: What Have we Learnt from Targeting CD20 and Where Are We Going?
Michael J. E. Marshall et al.
FRONTIERS IN IMMUNOLOGY (2017)
Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors
Beate Hintersteiner et al.
MABS (2016)
Backbone 1H, 13C, and 15N resonance assignments of the Fc fragment of human immunoglobulin G glycoprotein
Hirokazu Yagi et al.
BIOMOLECULAR NMR ASSIGNMENTS (2015)
Development of a Cell-Based Assay Measuring the Activation of FcγRIIa for the Characterization of Therapeutic Monoclonal Antibodies
Minoru Tada et al.
PLOS ONE (2014)
The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation
Mami Shibata-Koyama et al.
GLYCOBIOLOGY (2009)
Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities
A. Gonzalez-Quintela et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1
Shigeki Matsumiya et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G
S Preithner et al.
MOLECULAR IMMUNOLOGY (2006)
Characterization of the low molecular weight human serum proteome
RS Tirumalai et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
The structure of a human type III Fcγ receptor in complex with Fc
S Radaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)